Search

A mouse model of Lafora disease, a severe form of progressive myoclonus epilepsy, has shown alterations in the glutamatergic and GABAergic signaling pathways in the brain. The accumulation of insoluble deposits called Lafora bodies (LBs) is believed to be related to the characteristic features of the disease. The activation of inflammatory signaling pathways, specifically TNF and IL-6, has been found to contribute to the dysregulation of glutamatergic receptors and the GABA transporter in the hippocampus. These findings suggest that glial cells play a significant role in the pathophysiology of Lafora disease. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

According to a preprint abstract, researchers have studied the response of unipolar brush cells (UBCs) in the cerebellar cortex to different patterns of mossy fiber (MF) inputs. They found that UBCs exhibit a continuum of temporal responses mediated by three types of glutamate receptors. AMPARs transmit timing information for single stimuli, while a combination of mGluR2/3s and mGluR1s mediates delayed and prolonged responses to longer bursts of MF activation. These findings suggest that UBCs are flexible circuit elements that contribute to specialized processing in different regions of the cerebellar cortex. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

Auburn University researchers have found that troriluzole, a glutamate modulator, can rescue deficits in glutamatergic function, amyloid and tau pathology, and synaptic and memory impairments in a mouse model of Alzheimer's disease. The study suggests that presynaptic alterations are early events in Alzheimer's disease and could be potential targets for therapeutic intervention. Troriluzole treatment reduced glutamate release and restored cognitive deficits in the mice. These findings support the potential of glutamate-modulating drugs like troriluzole in the treatment of Alzheimer's disease. [Extracted from the article]

A recent study conducted at the University of Minnesota has found that astrocyte N-adrenergic receptor activity plays a role in regulating NMDA receptor signaling in the medial prefrontal cortex. The researchers discovered that norepinephrine and n-adrenergic receptor agonists increased the volume of astrocyte processes, which in turn reduced extrasynaptic NMDA receptor recruitment and glutamate spillover. These findings suggest that astrocyte n-adrenergic receptor activity can modulate synaptic physiology and may have implications for understanding the role of catecholamine receptors in the central nervous system. The study was supported by the National Institutes of Health. [Extracted from the article]

Researchers at Kanazawa University in Japan have conducted a study on the renal accumulation of radiogallium-labeled peptides containing different optical isomers of glutamic acid. The study found that the accumulation and retention of these compounds in the kidney varied depending on the isomer used. Specifically, the compound with d-Glu-l-Glu isomer exhibited the lowest level of kidney accumulation. The researchers suggest that using repeated d- and l-peptides may be a useful method for reducing renal accumulation in certain cases. This research provides valuable insights into the potential use of amino acids in bone-seeking radiopharmaceuticals. [Extracted from the article]

Researchers at the University of Bonn have published a study on ischemia, a condition that leads to a dysregulation of glutamate homeostasis and cell damage in the brain. The study found that shorter episodes of energy depletion can perturb glutamate signaling, while longer episodes result in a failure of synaptic transmission. The research also discovered differences in the vulnerability of cellular mechanisms, with postsynaptic cells being the most vulnerable to metabolic stress. The findings suggest that short perturbations of energy supply can increase glutamate excitotoxicity beyond the initial incident. [Extracted from the article]

A recent preprint study investigated the neuromuscular activity of swallowing and breathing integration in mouse models of Leigh Syndrome (LS), a neurometabolic disorder. The study focused on a genetic mouse model of LS in which the NDUFS4 gene was knocked out specifically in Vglut2 or Gad2 neurons. The researchers found that the mice exhibited increased variability in the swallow motor pattern, disruption in breathing regeneration post-swallow, and water-induced apneas. These findings suggest that the swallow impairments and swallow-breathing dyscoordination observed in the mouse models of LS are similar to those seen in patients with LS. The study highlights the importance of understanding these aspects of LS for the development of more effective therapeutic interventions. [Extracted from the article]

A recent study conducted at Henry Ford Hospital focused on understanding the role of cancer-associated fibroblasts (CAFs) in pancreatic cancer. CAFs are responsible for creating an immunosuppressive environment in tumors, hindering the effectiveness of immunotherapies. The researchers found that CAFs produce high levels of glutamate, which can be converted into gamma-aminobutyric acid (GABA), a major immunosuppressive metabolite. Interestingly, the study discovered a non-canonical pathway used by CAFs to produce GABA, involving the expression of specific enzymes. Further research aims to identify the cytokine profile of CAFs and analyze tumor interstitial fluid to improve clinical outcomes for pancreatic cancer patients. [Extracted from the article]

A recent study conducted by researchers at the Division of Endocrinology in Boston Children's Hospital examined the impact of testosterone treatment on the intestinal microbiome of transgender individuals. The study found that while there was a modest impact on the community structure of the microbiome, there was an increase in the abundance of metabolic pathways that generate glutamate and spare glutamate consumption. The researchers hypothesize that testosterone increases the uptake of glutamate by enterocytes, reducing the availability of this amino acid for the microbiome. Further research is needed to fully understand the implications of these findings. [Extracted from the article]

A report from Rani Channamma University in Belagavi, India discusses the synthesis and evaluation of 3-methyl-4-(hetero)arylmethylene isoxazole-5(4H)-one derivatives as potential anticancer agents. The compounds were synthesized using a multi-component reaction catalyzed by a novel organocatalyst. The derivatives were then screened against the MCF-7 breast cancer cell line and showed promising activity. Molecular docking, dynamics simulations, and electrochemical analysis further demonstrated potential antioxidant properties. The research suggests that these derivatives could be potential drug candidates for cancer therapy. [Extracted from the article]

A recent study conducted by researchers at the University of Bristol in the United Kingdom has found that luciferase-based immunoprecipitation system (LIPS) assays offer improved specificity in measuring autoantibodies to glutamate decarboxylase (GADA) compared to traditional radiobinding assays (RBAs). The study evaluated the performance of LIPS assays using different GAD65 constructs in serum samples from patients with type 1 diabetes and their relatives. The researchers found that Nluc-GAD65(96-585) LIPS assays demonstrated high specificity and required less serum than RBAs, making them a potential alternative for screening and diagnostics. This research was supported by various organizations including the Juvenile Diabetes Research Foundation and Diabetes UK. [Extracted from the article]

A study conducted by researchers at Oklahoma State University explores the role of palmitic acid, a saturated fatty acid found in high-fat diets, in regulating sympathetic outflow in human brainstem astrocytes (HBAs). The study found that palmitic acid treatment led to increased oxidative stress, DNA damage, cellular senescence, and downregulation of glutamate reuptake transporters in HBAs. These findings suggest a potential link between excitotoxicity in brainstem neurons, sympathoexcitation, and an increased risk for cardiovascular diseases in obesity. Further research is needed to better understand the mechanisms underlying these associations. [Extracted from the article]

A study conducted at the University of Wisconsin - Milwaukee explores the role of astrocytic glutamate transport in the memory-enhancing effects of 17b-estradiol in ovariectomized mice. The researchers found that the infusion of 17b-estradiol into the dorsal hippocampus of mice enhances memory consolidation, which depends on the rapid phosphorylation of extracellular signal-regulated kinase (ERK) and Akt. The study suggests that astrocytic function in the dorsal hippocampus is necessary for memory formation and is regulated by 17b-estradiol, highlighting the essential role of astrocytic glutamate transport in the memory-enhancing effects of 17b-estradiol. [Extracted from the article]

A report from Yale University discusses new research findings on spinal cord injury and its impact on spasticity, a hyperexcitability disorder that affects functional recovery. The study focuses on the role of astrocytes, a type of cell in the central nervous system, in post-injury hyperreflexia and plasticity of neighboring neuronal synaptic dendritic spines. The researchers found that selective Rac1KO in astrocytes reduced hyperreflexia and dendritic spine dysgenesis, potentially enhancing glutamate clearance and reducing spasticity. These findings suggest that targeting cell-specific molecular regulators could be a potential strategy for managing spasticity after spinal cord injury. [Extracted from the article]

A recent study conducted at Fairfield University in Connecticut has found that prolonged social isolation during adolescence can have long-term effects on brain development and behavior, increasing the risk of developing anxiety disorders. The study focused on Long Evans rats and observed sex differences in behavior and glutamic acid decarboxylase (GAD) expression. Female rats showed increased anxiety and reduced neophilic measures after isolation, while males showed no effect. The study suggests that prolonged social isolation in adolescence is anxiogenic for female rats and that sex and housing impact hippocampal GABA-ergic activity, which may have implications for the treatment of anxiety disorders. [Extracted from the article]

L.E.A.F. Holdings Group LLC has been granted a patent for alpha polyglutamated antifolates, which can be used to treat diseases like cancer, immune system disorders, and infectious diseases. The patent explains how these antifolates can be delivered directly into cells in a higher-level polyglutamate form, bypassing the need for the cells to convert them. This method aims to address the limitations and resistance often associated with antifolate therapy. The patent also includes claims for a liposomal composition that contains the alpha polyglutamated antifolate, providing detailed information about its composition and potential applications in cancer treatment. [Extracted from the article]

Cornell University has been issued a patent for compositions and methods for enhancing visual function. The patent describes a conjugate that includes an affinity agent, a branched linker, and two or more photoisomerizable regulators. The composition can be administered intraocularly and may be used to increase the sensitivity of retinal cells to light, confer light responsiveness on retinal cells, or treat ocular disorders characterized by reduced responsiveness to light. The patent provides detailed claims and descriptions of the composition and its components. [Extracted from the article]

A patent has been issued to Accelerated Biosciences Corp. for precursory regulatory cytotrophoblast cells and their potential uses in stem cell therapies. The patent describes an isolated population of cells that express various proteins and receptors, including human chorionic gonadotropin, insulin, heat shock proteins, and cytokines. These cells may have applications in treating a variety of diseases and conditions. The patent also includes claims for pharmaceutical compositions containing these cells and an acceptable carrier. Further research and development are needed to explore the potential of these cells in medical treatments. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the development of novel variants of the iGluSnFR3 glutamate sensor for imaging high frequency glutamate release in neuronal activity. The iGluSnFR3 generation has been developed with increased dynamic range and rapid on-kinetics, making it attractive for in vivo imaging. However, the off-kinetics of iGluSnFR3 limit its ability to resolve high frequency release. The researchers generated and characterized iGlu3fast, an ultrafast decay variant of iGluSnFR3, which showed improved decay rate and fluorescence dynamic range compared to iGluSnFR3. This research has not been peer-reviewed. [Extracted from the article]

A study conducted by the China National Clinical Research Center for Neurological Diseases investigated the levels of gamma-aminobutyric acid (GABA) and glutamate/glutamine (Glx) in patients with New daily persistent headache (NDPH). The study used magnetic resonance spectroscopy (MRS) to analyze the neurotransmitter levels in the periaqueductal gray (PAG) and dentate nucleus (DN) of the brain. The results showed that there were no significant differences in GABA and Glx levels between NDPH patients and healthy controls. However, certain clinical scales were found to be correlated with the neurotransmitter levels, suggesting a relationship between NDPH symptoms and these levels. [Extracted from the article]

A new study conducted by researchers at National Cheng Kung University and Academia Sinica in Taiwan explores the role of spinal astrocytes in the development of chronic pain. The study focuses on hyperalgesic priming, a form of pain plasticity that leads to heightened sensitivity to subsequent noxious stimuli. The researchers found that spinal astrocytes are essential for the formation of hyperalgesic priming in a mouse model of acid-induced muscle pain. They also discovered that astrocyte activation is dependent on spinal phosphorylated extracellular regulated kinase (pERK) and astrocytic glutamate transporters. The findings suggest that spinal astrocytes play a crucial role in the transition from acute to chronic pain. [Extracted from the article]

A recent study conducted by researchers at Auburn University has shown that a new drug called troriluzole can prevent brain changes associated with memory loss and cognitive decline in a mouse model of Alzheimer's disease. This is the first study to demonstrate how troriluzole can target early-stage alterations in Alzheimer's, offering hope for potential treatments. The drug reduced harmful glutamate levels and improved memory and learning in the mice, suggesting a maintenance of healthy brain function. Further studies are needed to determine how troriluzole works at different stages of disease progression. [Extracted from the article]

A clinical trial, NCT06580145, is being conducted to investigate the effects of a 6-week leucine challenge on brain chemistry, connectivity, and behavior in individuals with midlife depression. The study aims to compare the effects of leucine and an active comparator arm (lysine) over the course of 6 weeks. Depression is a common mental health condition that can greatly impact a person's quality of life, and symptoms such as loss of pleasure in activities and slowed movements may indicate a higher risk of dementia later in life. Inflammation in the body, particularly in middle-aged adults, may contribute to depression, and the kynurenine pathway, activated by inflammation, can produce substances toxic to brain cells. Leucine, a nutrient found in certain foods, may help prevent these toxic substances from entering the brain. The study will use brain scans and symptom assessments to determine if leucine improves brain function and reduces depression in middle-aged adults with signs of inflammation. This research study aims to explore the connection between inflammation and mental health, specifically focusing on depression. The study is currently in the interventional phase and will randomize participants into different treatment groups. The primary goal of the study is to develop new treatments for depression and potentially reduce the risk of dementia in individuals with depression. The study is not yet recruiting participants and is expected to be completed by July 2029. Eligible participants must have a diagnosis of major depression and moderate to severe depression symptoms. The [Extracted from the article]

A recent study conducted by researchers at Copenhagen University Hospital explored the relationship between structural and functional connectivity and executive functions in antipsychotic-naive patients with schizophrenia. The study involved cognitive testing, diffusion weighted imaging, and resting state functional magnetic resonance imaging on 64 patients with schizophrenia and 95 matched controls. The findings revealed that patients with schizophrenia exhibited cognitive impairments in executive functions compared to controls, and there were differences in the associations between structural and functional connectivity and executive functions in patients compared to controls. The study suggests that structural and functional connectivity may play a role in executive function deficits in patients with schizophrenia. [Extracted from the article]

A recent report from the Lithuanian University of Health Sciences discusses the association between cerebellar ataxia and autoimmune causes, specifically anti-GAD65 antibodies. The report presents a clinical case of a 52-year-old woman with symptoms such as dizziness, impaired coordination, occasional choking, and slurred speech. Diagnostic procedures revealed the presence of anti-GAD65 antibodies and atrophic changes in the cerebellum, leading to a diagnosis of anti-GAD65 antibody-associated cerebellar ataxia. Corticosteroids were found to be an effective treatment method, and maintenance therapy is recommended to prevent relapse. [Extracted from the article]

A recent study conducted by the European Brain Research Institute has found that inhibiting the colony stimulating factor 1-receptor (CSF-1R) can lead to the clearance of amyloid-beta (Ab) from glutamatergic terminals in the brain. This clearance of Ab is associated with the restoration of long-term potentiation (LTP) and excitatory transmission, which are often impaired in Alzheimer's disease (AD). The study suggests that targeting CSF-1R could be a potential disease-modifying approach for AD. The findings highlight the role of microglia, traditionally considered immune cells, in driving neuroinflammation and synaptic dysfunction in the early stages of AD. [Extracted from the article]

A patent application titled "Peptide Nucleic Acids For Spatiotemporal Control Of Crispr-Cas Binding" has been published online. The inventors propose compositions and methods for modulating the localization and activity of CRISPR/Cas systems. The compositions include single-stranded peptide nucleic acid (ssPNA) oligomers that hybridize to the spacer sequence of an unbound or Cas9-bound guide RNA, forming a PNA:RNA duplex. These ssPNA oligomers can reduce the activity of CRISPR/Cas at the target site and can be used in combination with other ssPNA oligomers to modulate multiple sites simultaneously. Pharmaceutical compositions containing these ssPNA oligomers are also provided. [Extracted from the article]

A study conducted at Zhengzhou University in China investigated the effects of Qi Wei anti-burn Tincture (QW) on wound healing in burnt mice. The researchers used metabolomics and molecular biology techniques to analyze the molecular mechanism of QW. The study found that QW treatment promoted the healing of burn wounds in mice by remodeling metabolic pathways in the liver. The researchers also observed changes in biochemical indicators, differential metabolites, and inflammatory factors in the liver tissue of the mice. This research provides insights into the potential mechanism of QW in treating burn wounds. [Extracted from the article]

The article details how research on human-derived neuronal cell models has advanced the understanding of ADHD. Topics include evidence of mitochondrial dysfunction and impaired energy metabolism in ADHD models, altered neuronal development, and abnormalities in glutamatergic signalling. The findings suggest that these models could be valuable for developing new, individualized therapeutic approaches.

Researchers at the Institute of Cell Biophysics of the Russian Academy of Sciences have conducted a study on ischemia, a condition caused by reduced blood flow to the brain. They sought to find effective cytoprotectors, or substances that can protect cells from damage, to combat cerebral ischemia. In their study, they developed a recombinant protein called SELENOM, which demonstrated antioxidant properties and was able to suppress the production of reactive oxygen species (ROS) in cortical cells. The researchers concluded that SELENOM increased antioxidant protection in cortical cells and suppressed proinflammatory factors and cytokines expression. [Extracted from the article]

A recent study conducted at Aston University explored the potential of using the buccal route as an alternative method for administering the glycopeptide antibiotic vancomycin. The researchers coated vancomycin with L-glutamic acid using an isothermal dry particle coater, which significantly increased the drug's permeability through the buccal cell line. Microbiology experiments confirmed the antimicrobial activity of the coated vancomycin particles. This study demonstrates a novel approach to delivering large molecule drugs through controlled deposition of amino acids, offering a non-invasive and potentially more effective method of administration. [Extracted from the article]

The article discusses a U.S. patent issued to Astellas Pharma Inc., focusing on a pharmaceutical composition involving antibody Fab fragment conjugates used for cancer diagnosis. It explains how these Fab fragments, bound to fluorescent dyes or metal radioisotopes, offer enhanced diagnostic efficacy due to their smaller size, faster blood clearance, and reduced side effects compared to full antibodies.

The article reports on a recently published patent application for the use of esketamine in treating depression, specifically focusing on methods for addressing major depressive disorder (MDD) and treatment-resistant depression (TRD). Topics discussed include the clinical efficacy and safety of esketamine, its potential long-term use and combination with other antidepressants, and methods for maintaining remission in patients with severe depression.

Researchers at Southern Medical University in Guangdong, China have developed a novel hybrid hydrogel for repairing osteoporotic bone defects. The hydrogel, called PGA-DA &T4, combines a bioactive hydrophilic nanocage with gamma-polyglutamic acid (gamma-PGA) and dopamine. The hydrogel demonstrated favorable injectability, shape-adaptivity, self-healability, and antioxidant ability. In vitro experiments showed that the hydrogel is biocompatible, promotes cell migration and neovascularization, and accelerates osteogenic differentiation while inhibiting osteoclastogenesis. This research provides a promising biomaterial for potential clinical application in bone regeneration. [Extracted from the article]

According to a preprint abstract, the maturation of the prefrontal cortex (PFC) during adolescence is a critical period for executive function. This maturation is driven by a balance between glutamatergic excitation and GABAergic inhibition neurotransmission. The study used 7T MR spectroscopy and EEG to examine the associations between age-related changes in glutamate and GABA neurotransmitters and cortical signal-to-noise ratio (SNR). The findings suggest that developmental decreases in spontaneous activity and increases in cortical SNR are associated with improvements in working memory performance, indicating plasticity in the human PFC during adolescence. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A study conducted at the Federal University Rio de Janeiro in Brazil explored the relationship between gut microbiota and anxiety and depression symptoms in young, healthy adults. The researchers used metabolomics to analyze fecal metabolic profiles and found that certain metabolites, such as acetate, valerate, and glutamate, were associated with differences in anxiety and depression scores and heart rate variability. The study also identified differences in the Firmicutes phylum between participants with high and low vagal tone, suggesting a connection between specific metabolites and communication between the vagus nerve and the brain. This research provides further evidence of the impact of gut-brain interactions on mental health. [Extracted from the article]

A study conducted by researchers at Pennsylvania State University (Penn State) explores the role of astrocytes in nicotine reinforcement and relapse. The study found that chronic nicotine exposure increased the expression of the astrocyte marker glial fibrillary acidic protein (GFAP) in the nucleus accumbens core (NACcr). Inhibition of astrocytes using fluorocitrate reduced nicotine self-administration and cue-induced reinstatement of nicotine seeking. Additionally, fluorocitrate altered extracellular levels of glutamate and dopamine in the NACcr. These findings suggest that astrocytes play a critical role in nicotine reinforcement and relapse through the regulation of neurotransmission. [Extracted from the article]

According to a preprint abstract, sleep loss has been found to increase AMPA-synaptic strength and number in the neocortex. Additionally, there is an increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2-3. These changes in synaptic response to sleep loss are recovered by sleep, and sleep genes are enriched for cellular components controlling glutamate synapse phenotype. These findings suggest that sleep genes play a role in motor learning and training through the oscillation of glutamate-synaptic phenotypes. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at Complutense University in Madrid, Spain, has found that the protein GAP43 plays a crucial role in regulating the excitatory-inhibitory balance in the brain. The researchers generated mice with the GAP43 gene selectively inactivated in either glutamatergic or GABAergic neurons and observed that mice lacking GAP43 in glutamatergic neurons exhibited hyperactive behavior when exposed to a novel environment. This hyperactivity was linked to increased activation of dorsal-striatum neurons and enhanced corticostriatal glutamatergic transmission. The findings suggest that GAP43 may be involved in the development of psychiatric disorders characterized by novelty-induced hyperactivity, such as attention deficit/hyperactivity disorder, schizophrenia, and bipolar disorder. [Extracted from the article]

Researchers at Shanxi Medical University in Taiyuan, China have developed a new sunscreen hydrogel that can prevent and treat skin damage caused by excessive ultraviolet (UV) radiation. The hydrogel, called Carb@PDA-L, is made by doping melanin-like L-lysine doped polydopamine (PDA-L) into a biocompatible poly-gamma-glutamic acid based hydrogel matrix. It has been found to have good biosafety, efficient UV shielding performance, and excellent antioxidative and anti-inflammatory properties. The research was supported by various funding sources and has been peer-reviewed. [Extracted from the article]